← Leaderboards
Sirano Dhe-Paganon
Brigham And Women'S Hospital
$892,205
Attributed
$1,784,410
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $636.8K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,784,410 · 1
By mechanism
R01$1,784,410 · 1
Top collaborators
- Bradley Maron3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Raul San Jose Estepar$11,331,173
- Stephen Y Chan$16,563,292
- Bradley Maron$8,442,424
- George R Washko$16,445,968
- Bradley Wertheim$1,908,343
Others in their field
Other Rising Stars on “Ablation”
- Amar Nijagal · University Of California, San Francisco$3,176,680
- Rana Ramzi McKay · University Of California, San Diego$2,984,495
- Dhiraj Kumar Singh · Texas Biomedical Research Institute$2,910,982
- Francisco Altamirano · Methodist Hospital Research Institute$2,811,457
- Qin Zheng · Johns Hopkins University$2,714,830
- Robert Nathaniel Helsley · University Of Kentucky$2,651,504
Research focus
AblationAdverse OutcomeAffectAffinityAnalogAngiogenesisAnimal ModelArterial DisorderArteriesArterioleAttenuatedBindingBlood VesselsBody SystemCancer Cell LineCell LineCell ProliferationCellsCell TypeCessation Of LifeComplexConnective TissueDesign3-Dimensional
Grant awards (3)
Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension$576,691
R01 · FY2025 · HL
Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension$570,887
R01 · FY2024 · HL
Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension$636,832
R01 · FY2023 · HL